The “Big 3” pharmacy benefit managers – CVS Caremark, Express Scripts and OptumRx – mark up specialty drugs at their affiliated pharmacies by hundreds or even thousands of percent, according to a new interim staff report from the Federal Trade Commission.
FTC says top three PBMs made $7.3 billion from marked up drug prices
